<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>39(11)</volume><submitter>Iwata M</submitter><funding>Mochida Pharmaceutical Co., Ltd.</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown.&lt;h4>Methods&lt;/h4>We identified studies by searching the MEDLINE, Cochrane Library, and ICHUSHI databases and included randomized controlled trials (RCTs) that used total dysmenorrhea score and visual analogue scale (VAS) as outcome measures to evaluate LEPs and progestins for primary and secondary dysmenorrhea. We analyzed results by meta-analysis and network meta-analysis (NMA).&lt;h4>Results&lt;/h4>We identified 10 articles on eight RCTs and included seven drugs (six LEPs and one progestin, i.e., dienogest) and placebo in the analysis. Meta-analysis showed improvements in total d</pubmed_abstract><journal>Advances in therapy</journal><pagination>4892-4909</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9525387</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis.</pubmed_title><pmcid>PMC9525387</pmcid><pubmed_authors>Shoji A</pubmed_authors><pubmed_authors>Oikawa Y</pubmed_authors><pubmed_authors>Sakashita N</pubmed_authors><pubmed_authors>Iwata M</pubmed_authors><pubmed_authors>Shimizu Y</pubmed_authors><pubmed_authors>Igarashi A</pubmed_authors><pubmed_authors>Osuga Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis.</name><description>&lt;h4>Introduction&lt;/h4>Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown.&lt;h4>Methods&lt;/h4>We identified studies by searching the MEDLINE, Cochrane Library, and ICHUSHI databases and included randomized controlled trials (RCTs) that used total dysmenorrhea score and visual analogue scale (VAS) as outcome measures to evaluate LEPs and progestins for primary and secondary dysmenorrhea. We analyzed results by meta-analysis and network meta-analysis (NMA).&lt;h4>Results&lt;/h4>We identified 10 articles on eight RCTs and included seven drugs (six LEPs and one progestin, i.e., dienogest) and placebo in the analysis. Meta-analysis showed improvements in total d</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-22T03:33:24.813Z</modification><creation>2025-02-19T00:23:32.376Z</creation></dates><accession>S-EPMC9525387</accession><cross_references><pubmed>36048405</pubmed><doi>10.1007/s12325-022-02298-9</doi></cross_references></HashMap>